Grifulvin V
This medicine is indicated for dermatophyte fungal infections utilized to alleviate skin conditions and support healing of systemic fungal colonies.
Strengths: 250mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Fulicin
- Therapeutic class
Antifungal
- Pharmacological class
Benzofuran derivative
- Contraindications
hypersensitivity to griseofulvin; severe liver disease; porphyria
- Precautions and warnings
avoid prolonged sun and UV exposure; regular liver function monitoring
- Minor side effects
headache; nausea; diarrhoea
- Moderate side effects
rash; fatigue; dizziness
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Amdipharm
- Onset Time
1–2 weeks
- Duration
4–8 weeks
- Storage instructions
Store at room temperature away from light.
- Drug interactions
Alcohol; Warfarin
- Age restrictions
Use as directed by a specialist.
- Pregnancy and breastfeeding
Pregnancy: Must not be used. Breastfeeding: Consult a physician.
Serious side effects
hepatotoxicity — requires immediate medical attention; Stevens-Johnson syndrome — requires immediate medical attention
Patient summary
This medicine is indicated for dermatophyte fungal infections utilized to alleviate skin conditions and support healing of systemic fungal colonies.
Mechanism of action
Griseofulvin inhibits fungal cell mitosis by binding to microtubular proteins and disrupting the mitotic spindle, preventing fungal growth.
Grifulvin V
This medicine is indicated for dermatophyte fungal infections utilized to alleviate skin conditions and support healing of systemic fungal colonies.
Editorial Notes
- Active ingredient(s): Griseofulvin
- Listed indication(s): Tinea Capitis, Tinea Corporis, Tinea Pedis
Available option
- 180 tablets - 250 mg445-250-mg-3130